+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI in Patient Scheduling Software Market Forecast to 2033

  • PDF Icon

    Report

  • 100 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189443
REQUEST CUSTOMIZATION
Description Jump to:
The global AI in patient scheduling software market size was estimated at USD 63.04 million in 2024 and is projected to reach USD 555.09 million by 2033, growing at a CAGR of 27.64% from 2025 to 2033. Growing need to reduce administrative inefficiencies and improve healthcare resource utilization, rapid digital transformation across healthcare systems, and the rise of telehealth and value-based care models are some factors contributing to market growth.

In addition, rising patient volumes, chronic disease burden, and increasing emphasis on patient-centric care and convenience contribute to market growth. The adoption of AI in patient scheduling software is primarily driven by the need to reduce administrative inefficiencies and improve healthcare resource utilization. Traditional manual scheduling systems often lead to bottlenecks, double bookings, and extended patient wait times. AI-powered platforms optimize appointment allocation by analyzing real-time provider availability, patient preferences, and clinical urgency. This results in higher operational efficiency, reduced no-show rates, and improved patient throughput. In addition, due to the rising patient volumes, healthcare providers are increasingly adopting AI scheduling systems to streamline workflows. For instance, in February 2025, Innovaccer introduced “Agents of Care,” a suite of AI agents for healthcare providers that automate low-value healthcare administrative tasks like appointment scheduling, protocol intake, referral management, and patient inquiries.

Moreover, increasing emphasis on enhancing patient experience through digital engagement and convenience propels the growth of the AI in patient scheduling software industry. Patients increasingly expect seamless self-service options such as online booking and real-time rescheduling, similar to experiences in other consumer industries. AI scheduling systems facilitate this by offering patient-friendly portals and mobile applications with intelligent recommendations based on prior visits, treatment timelines, and provider availability. These solutions improve patient satisfaction, encourage adherence to follow-up care, and foster trust in healthcare providers. For instance, in May 2025, Epic Systems introduced a conversational AI tool that enables patients to schedule appointments via SMS without logging into a portal or waiting on hold. The AI assistant initiates scheduling conversations, offers appointment slots, confirms bookings, and provides MyChart links for details or virtual check-in.

The rise of telehealth and value-based care models highlights the increasing use of AI in patient scheduling software. Virtual care platforms depend on intelligent scheduling systems to manage a high volume of digital appointments while coordinating providers across different geographies and time zones. Similarly, value-based care models necessitate precise scheduling to minimize delays in care, ensure timely interventions, and optimize patient outcomes. For instance, in July 2025, Rush University System for Health launched Rush Connect+, a national direct-to-consumer telehealth membership offering 24/7 virtual urgent care. The service includes access to a human assistant for scheduling appointments and answering questions, AI-powered chatbots, symptom checkers, and same-day specialty care in eight areas.

Global AI In Patient Scheduling Software Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global AI in patient scheduling software market report based on scheduling type, deployment mode, end use, and region:

Scheduling Type Outlook (Revenue, USD Million, 2021-2033)

  • Outpatient Scheduling
  • Inpatient Scheduling
  • Specialty Care Scheduling
  • Emergency & Urgent Care Scheduling
  • Others

Deployment Mode Outlook (Revenue, USD Million, 2021-2033)

  • Cloud-based
  • On-Premises

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Clinics
  • Diagnostic & Imaging Centers
  • Ambulatory Surgical Centers (ASCs)
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MEA

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Scheduling Type Segment
1.2.2. Deployment Mode Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Mode
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. AI in Patient Scheduling Software Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. AI in Patient Scheduling Software Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
3.4. Case Study Insights
3.5. Technology Overview
Chapter 4. AI in Patient Scheduling Software Market: Scheduling Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global AI in Patient Scheduling Software Market Scheduling Type Movement Analysis
4.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by Scheduling Type, 2021 to 2033 (USD Million)
4.4. Outpatient Scheduling
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Inpatient Scheduling
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Specialty Care Scheduling
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.7. Emergency & Urgent Care Scheduling
4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. AI in Patient Scheduling Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global AI in Patient Scheduling Software Market Deployment Mode Movement Analysis
5.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
5.4. Cloud-based
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. on-Premises
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. AI in Patient Scheduling Software Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global AI in Patient Scheduling Software Market End Use Movement Analysis
6.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Clinics
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Diagnostic & Imaging Centers
6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Ambulatory Surgical Centers (ASCs)
6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. AI in Patient Scheduling Software Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Veradigm LLC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Hyro
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Epic Systems Corporation
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Assort Health
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Notable
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Voiceoc
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Zocdoc
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Relatient
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. UnityAI, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global AI in patient scheduling software market, by region, 2021-2033 (USD Million)
Table 3 Global AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 4 Global AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 5 Global AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 6 North America AI in patient scheduling software market, by country, 2021-2033 (USD Million)
Table 7 North America AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 8 North America AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 9 North America AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 10 U.S. AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 11 U.S. AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 12 U.S. AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 13 Canada AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 14 Canada AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 15 Canada AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 16 Mexico AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 17 Mexico AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 18 Mexico AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 19 Europe AI in patient scheduling software market, by country, 2021-2033 (USD Million)
Table 20 Europe AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 21 Europe AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 22 Europe AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 23 UK AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 24 UK AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 25 UK AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 26 Germany AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 27 Germany AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 28 Germany AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 29 France AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 30 France AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 31 France AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 32 Italy AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 33 Italy AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 34 Italy AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 35 Spain AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 36 Spain AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 37 Spain AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 38 Denmark AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 39 Denmark AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 40 Denmark AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 41 Sweden AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 42 Sweden AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 43 Sweden AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 44 Norway AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 45 Norway AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 46 Norway AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 47 Asia-Pacific AI in patient scheduling software market, by country, 2021-2033 (USD Million)
Table 48 Asia-Pacific AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 49 Asia-Pacific AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 50 Asia-Pacific AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 51 China AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 52 China AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 53 China AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 54 Japan AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 55 Japan AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 56 Japan AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 57 India AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 58 India AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 59 India AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 60 South Korea AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 61 South Korea AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 62 South Korea AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 63 Australia AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 64 Australia AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 65 Australia AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 66 Thailand AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 67 Thailand AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 68 Thailand AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 69 Latin America AI in patient scheduling software market, by country, 2021-2033 (USD Million)
Table 70 Latin America AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 71 Latin America AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 72 Latin America AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 73 Brazil AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 74 Brazil AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 75 Brazil AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 76 Argentina AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 77 Argentina AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 78 Argentina AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 79 MEA AI in patient scheduling software market, by country, 2021-2033 (USD Million)
Table 80 MEA AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 81 MEA AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 82 MEA AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 83 South Africa AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 84 South Africa AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 85 South Africa AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 86 Saudi Arabia AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 87 Saudi Arabia AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 88 Saudi Arabia AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 89 UAE AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 90 UAE AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 91 UAE AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
Table 92 Kuwait AI in patient scheduling software market, by scheduling type, 2021-2033 (USD Million)
Table 93 Kuwait AI in patient scheduling software market, by deployment mode, 2021-2033 (USD Million)
Table 94 Kuwait AI in patient scheduling software market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 AI in patient scheduling software market: Market outlook
Figure 5 AI in patient scheduling software market: Segment outlook
Figure 6 AI in patient scheduling software market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 AI in patient scheduling software market driver impact
Figure 9 AI in patient scheduling software market restraint impact
Figure 10 AI in patient scheduling software market: Scheduling type outlook and key takeaways
Figure 11 AI in patient scheduling software market: Scheduling type movement analysis
Figure 12 Outpatient scheduling market estimates and forecasts, 2021-2033 (USD Million)
Figure 13 Inpatient scheduling market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Specialty care scheduling market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Emergency & urgent care scheduling market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 AI in patient scheduling software market: Deployment mode outlook and key takeaways
Figure 18 AI in patient scheduling software market: Deployment mode movement analysis
Figure 19 Cloud-based market estimates and forecasts,2021-2033 (USD Million)
Figure 20 on-premises market estimates and forecasts,2021-2033 (USD Million)
Figure 21 AI in patient scheduling software market: End use outlook and key takeaways
Figure 22 AI in patient scheduling software market: End use movement analysis
Figure 23 Hospitals market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Clinics market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Diagnostic & imaging centers market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Global AI in patient scheduling software market: Regional outlook and key takeaways
Figure 29 Global AI in patient scheduling software market: Regional movement analysis
Figure 30 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 U.S. key country dynamics
Figure 32 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Canada key country dynamics
Figure 34 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Mexico key country dynamics
Figure 36 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 UK key country dynamics
Figure 39 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Germany key country dynamics
Figure 41 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 France key country dynamics
Figure 43 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Italy key country dynamics
Figure 45 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Spain key country dynamics
Figure 47 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Denmark key country dynamics
Figure 49 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Sweden key country dynamics
Figure 51 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Norway key country dynamics
Figure 53 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Japan key country dynamics
Figure 56 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 China key country dynamics
Figure 58 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 India key country dynamics
Figure 60 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Thailand key country dynamics
Figure 62 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 South Korea key country dynamics
Figure 64 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Australia key country dynamics
Figure 66 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Brazil key country dynamics
Figure 69 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Argentina key country dynamics
Figure 71 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 South Africa key country dynamics
Figure 74 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Saudi Arabia key country dynamics
Figure 76 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 UAE key country dynamics
Figure 78 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Kuwait key country dynamics
Figure 80 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this AI in Patient Scheduling Software market report include:
  • Veradigm LLC
  • Epic Systems Corporation
  • Hyro
  • Assort Health
  • Notable
  • Voiceoc
  • Zocdoc
  • Relatient
  • UnityAI, Inc.

Table Information

Report AttributeDetails
No. of Pages100
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 63.04 Million
Forecasted Market Value ( USD ) by 2033 $ 555.09 Million
Compound Annual Growth Rate27.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

AI in Medical Scheduling Software Market Forecast to 2033 - Product Image

AI in Medical Scheduling Software Market Forecast to 2033

  • Report
  • 100 Pages
  • Global
From
U.S. Healthcare Staffing And Scheduling Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web-Based, Cloud-based, On-Premises, Mobile Installed), By Application (Time & Attendance, Scheduling), By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Healthcare Staffing And Scheduling Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web-Based, Cloud-based, On-Premises, Mobile Installed), By Application (Time & Attendance, Scheduling), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 80 Pages
  • United States
From
Dental Practice Management Software Market Size, Share, Trends and Forecast by Deployment Type, Application, End User, and Region 2025-2033 - Product Image

Dental Practice Management Software Market Size, Share, Trends and Forecast by Deployment Type, Application, End User, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Operating Room Management Software Market Size, Share & Trends Analysis Report by Solution (Anesthesia Information Management, Data Management & Communication), Deployment, End Use, Region, and Segment Forecast, 2025-2033 - Product Image

Operating Room Management Software Market Size, Share & Trends Analysis Report by Solution (Anesthesia Information Management, Data Management & Communication), Deployment, End Use, Region, and Segment Forecast, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Appointment Scheduling Software Market Size, Share, Trends and Forecast by Type, Deployment Type, Organization Size, End Use Industry, and Region, 2025-2033 - Product Image

Appointment Scheduling Software Market Size, Share, Trends and Forecast by Type, Deployment Type, Organization Size, End Use Industry, and Region, 2025-2033

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.